Docosahexaenoic Acid Supplementation from Mid-pregnancy to Parturition Influenced Breast Milk Fatty Acid Concentrations at 1 Month Postpartum in Mexican Women

Overview

Journal J Nutr

Publisher Elsevier

Specialty Nutritional Sciences

Date 2010 Dec 24

PMID 21178076

Citations 21

Authors

Beth Imhoff-Kunsch

Aryeh D Stein

Salvador Villalpando

Reynaldo Martorell

Usha Ramakrishnan

Affiliations

Soon will be listed here.

Abstract

(n-3) PUFA, including DHA, are essential for neural development and accumulate extensively in the fetal and infant brain. (n-3) PUFA concentrations in breast milk, which are largely dependent on maternal diet and tissue stores, are correlated with infant PUFA status. We investigated the effect of prenatal DHA supplementation on PUFA concentrations in breast milk at 1 mo postpartum. In a double-blind, randomized, controlled trial conducted in Mexico, pregnant women were supplemented daily with 400 mg DHA or placebo from 18-22 wk gestation to parturition. Fatty acid concentrations in breast milk obtained from 174 women at 1 mo postpartum were determined using GLC and were expressed as % by weight of total detected fatty acids. Breast milk DHA concentrations in the DHA and placebo groups were (mean ± SD) 0.20 ± 0.06 and 0.17 ± 0.07 (P < 0.01), respectively, and those of α-linolenic acid (ALA) were 1.38 ± 0.47 and 1.24 ± 0.46 (P = 0.01), respectively. Concentrations of EPA and arachidonic acid did not differ between groups (P > 0.05). Maternal plasma DHA concentrations at 1 mo postpartum correlated positively with breast milk DHA at 1 mo postpartum in both the placebo and DHA groups (r = 0.4; P < 0.01 for both treatment groups). Prenatal DHA supplementation from 18-22 wk gestation to parturition increased concentrations of DHA and ALA in breast milk at 1 mo postpartum, providing a mechanism through which breast-fed infants could benefit.

Citing Articles

Maternal circadian rhythm disruption affects neonatal inflammation via metabolic reprograming of myeloid cells.

Cui Z, Xu H, Wu F, Chen J, Zhu L, Shen Z Nat Metab. 2024; 6(5):899-913.

PMID: 38561509 DOI: 10.1038/s42255-024-01021-y.

Effects of vitamin and mineral supplementation during pregnancy on maternal, birth, child health and development outcomes in low- and middle-income countries: A systematic review.

Keats E, Oh C, Chau T, Khalifa D, Imdad A, Bhutta Z Campbell Syst Rev. 2023; 17(2):e1127.

PMID: 37051178 PMC: 8356361. DOI: 10.1002/cl2.1127.

Docosahexaenoic Acid Effect on Prenatal Exposure to Arsenic and Atopic Dermatitis in Mexican Preschoolers.

Figueroa-Garduno I, Escamilla-Nunez C, Barraza-Villarreal A, Hernandez-Cadena L, Onofre-Pardo E, Romieu I Biol Trace Elem Res. 2022; 201(7):3152-3161.

PMID: 36074245 DOI: 10.1007/s12011-022-03411-3.

Docosahexaenoic acid-rich algae oil supplementation on breast milk fatty acid profile of mothers who delivered prematurely: a randomized clinical trial.

Fougere H, Bilodeau J, Lavoie P, Mohamed I, Rudkowska I, Pronovost E Sci Rep. 2021; 11(1):21492.

PMID: 34728723 PMC: 8564506. DOI: 10.1038/s41598-021-01017-8.

Infant Metabolome in Relation to Prenatal DHA Supplementation and Maternal Single-Nucleotide Polymorphism rs174602: Secondary Analysis of a Randomized Controlled Trial in Mexico.

Tandon S, Gonzalez-Casanova I, Barraza-Villarreal A, Romieu I, Demmelmair H, Jones D J Nutr. 2021; 151(11):3339-3349.

PMID: 34494106 PMC: 8562085. DOI: 10.1093/jn/nxab276.

References

Boris J, Jensen B, Salvig J, Secher N, Olsen S . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids. 2005; 39(12):1191-6. DOI: 10.1007/s11745-004-1347-7. View

Ozias M, Carlson S, Levant B . Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J Nutr. 2006; 137(1):125-9. DOI: 10.1093/jn/137.1.125. View

Brenna J, Varamini B, Jensen R, Diersen-Schade D, Boettcher J, Arterburn L . Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007; 85(6):1457-64. DOI: 10.1093/ajcn/85.6.1457. View

Makrides M, Gibson R, McPhee A, Yelland L, Quinlivan J, Ryan P . Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010; 304(15):1675-83. DOI: 10.1001/jama.2010.1507. View

Innis S . Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008; 1237:35-43. DOI: 10.1016/j.brainres.2008.08.078. View

Freeman M . Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot Essent Fatty Acids. 2006; 75(4-5):291-7. DOI: 10.1016/j.plefa.2006.07.007. View

Maluccio J, Melgar P, Mendez H, Murphy A, Yount K . Social and economic development and change in four Guatemalan villages: demographics, schooling, occupation, and assets. Food Nutr Bull. 2005; 26(2 Suppl 1):S25-45. DOI: 10.1177/15648265050262S104. View

Olsen S, Secher N . A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr. 1990; 64(3):599-609. DOI: 10.1079/bjn19900063. View

Koletzko B, Larque E, Demmelmair H . Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J Perinat Med. 2007; 35 Suppl 1:S5-11. DOI: 10.1515/JPM.2007.030. View

10.

Hibbeln J . Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002; 69(1-3):15-29. DOI: 10.1016/s0165-0327(01)00374-3. View

11.

Lauritzen L, Jorgensen M, Olsen S, Straarup E, Michaelsen K . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr Dev. 2005; 45(5):535-47. DOI: 10.1051/rnd:2005044. View

12.

Villalpando S, Butte N, Thotathuchery M . Qualitative analysis of human milk produced by women consuming a maize-predominant diet typical of rural Mexico. Ann Nutr Metab. 1998; 42(1):23-32. DOI: 10.1159/000012714. View

13.

Parra M, Schnaas L, Meydani M, Perroni E, Martinez S, Romieu I . Erythrocyte cell membrane phospholipid levels compared against reported dietary intakes of polyunsaturated fatty acids in pregnant Mexican women. Public Health Nutr. 2003; 5(6A):931-7. DOI: 10.1079/PHN2002381. View

14.

Hanebutt F, Demmelmair H, Schiessl B, Larque E, Koletzko B . Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr. 2008; 27(5):685-93. DOI: 10.1016/j.clnu.2008.05.010. View

15.

Xie L, Innis S . Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr. 2008; 138(11):2222-8. DOI: 10.3945/jn.108.096156. View

16.

Parra-Cabrera S, Stein A, Wang M, Martorell R, Rivera J, Ramakrishnan U . Dietary intakes of polyunsaturated fatty acids among pregnant Mexican women. Matern Child Nutr. 2011; 7(2):140-7. PMC: 6860638. DOI: 10.1111/j.1740-8709.2010.00254.x. View

17.

Lauritzen L, Jorgensen M, Mikkelsen T, Skovgaard L, Straarup E, Olsen S . Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids. 2004; 39(3):195-206. DOI: 10.1007/s11745-004-1220-8. View

18.

Morrison W, Smith L . PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. J Lipid Res. 1964; 5:600-8. View

19.

Ramakrishnan U, Stein A, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juarez-Marquez S . Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull. 2010; 31(2 Suppl):S108-16. DOI: 10.1177/15648265100312S203. View

20.

FIDLER N, Sauerwald T, Pohl A, Demmelmair H, Koletzko B . Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial. J Lipid Res. 2000; 41(9):1376-83. View